Loading... Please wait...

Alnylam Pharmaceuticals, Inc. (ALNY) Analyst Forecast

Currency in USD Disclaimer
$248.68 $1.07 (0.43%)
$245.48
$249.67
$141.98
$252.87
  • Consensus Rating

    Buy

    Based on 18 Analyst Ratings

  • Consensus Price Target

    $233.22

    -6.22% Downside

Recent Analyst Forecasts and Stock Ratings


Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside on Report Date Details
06/28/2024 UBS Esther Rajavelu $288.00 $247.00   16.6%
06/27/2024 RBC Capital Luca Issi $265.00 $245.17   8.09%
06/27/2024 Stifel Nicolaus Paul Matteis $295.00 $247.40   19.24%
06/25/2024 Evercore ISI Liisa Bayko $260.00 $222.90   16.64%
06/25/2024 RBC Capital Luca Issi $250.00 $222.90   12.16%
06/24/2024 Morgan Stanley Andrew Galler $250.00 $224.70   11.26%
06/24/2024 H.C. Wainwright Patrick Trucchio $400.00 $227.05   76.17%
06/24/2024 Stifel Nicolaus Paul Matteis $247.00 $227.92   8.37%
06/12/2024 RBC Capital Luca Issi $235.00 $156.43   50.23%
04/08/2024 BMO Capital Kostas Biliouris $234.00 $156.59   49.43%
12/15/2022 Piper Sandler Edward Tenthoff $253.00 $229.37   10.3%
07/12/2022 Cantor Fitzgerald Olivia Brayer $175.00 $145.85   19.99%
06/14/2022 Piper Sandler Edward Tenthoff $208.00 $135.83   53.14%
02/10/2022 BMO Capital Gary Nachman $175.00 $150.76   16.08%
02/10/2022 Berenberg Bank Zhiqiang Shu $154.00 $150.76   2.15%
02/09/2022 RBC Capital Luca Issi $225.00 $150.86   49.14%
02/02/2022 Guggenheim Debjit Chattopadhyay $170.00 $142.51   19.29%
01/25/2022 Bank of America Securities Tazeen Ahmad $209.00 $130.12   60.62%
01/22/2022 Jefferies Maury Raycroft $205.00 $136.53   50.15%
12/12/2021 Cowen & Co. Ritu Baral $250.00 $186.42   34.11%
11/21/2021 Goldman Sachs Salveen Richter $273.00 $187.01   45.98%
10/28/2021 Evercore ISI Maneka Mirchandaney $190.00 $159.56   19.08%
10/28/2021 UBS Esther Rajavelu $211.00 $159.56   32.24%
10/28/2021 Cantor Fitzgerald Alethia Young $275.00 $159.56   72.35%
10/27/2021 Barclays Gena Wang $210.00 $162.14   29.52%

Alnylam Pharmaceuticals, Inc. Frequently Asked Questions

  • Q. What analysts cover Alnylam Pharmaceuticals, Inc.?

    A. Alnylam Pharmaceuticals, Inc. has been rated by research analysts at UBS, RBC Capital, Stifel Nicolaus, Evercore ISI, Morgan Stanley, H.C. Wainwright in the past 90 days.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.